ATE173625T1 - Zusammensetzungen zur behandlung von hiv- infektionen - Google Patents

Zusammensetzungen zur behandlung von hiv- infektionen

Info

Publication number
ATE173625T1
ATE173625T1 AT92921278T AT92921278T ATE173625T1 AT E173625 T1 ATE173625 T1 AT E173625T1 AT 92921278 T AT92921278 T AT 92921278T AT 92921278 T AT92921278 T AT 92921278T AT E173625 T1 ATE173625 T1 AT E173625T1
Authority
AT
Austria
Prior art keywords
compositions
hiv infections
treating hiv
infections
undergoing
Prior art date
Application number
AT92921278T
Other languages
English (en)
Inventor
Jess G Thoene
Original Assignee
Jess G Thoene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jess G Thoene filed Critical Jess G Thoene
Application granted granted Critical
Publication of ATE173625T1 publication Critical patent/ATE173625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • External Artificial Organs (AREA)
AT92921278T 1991-09-30 1992-09-30 Zusammensetzungen zur behandlung von hiv- infektionen ATE173625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76780291A 1991-09-30 1991-09-30
US86521992A 1992-04-08 1992-04-08

Publications (1)

Publication Number Publication Date
ATE173625T1 true ATE173625T1 (de) 1998-12-15

Family

ID=27117960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921278T ATE173625T1 (de) 1991-09-30 1992-09-30 Zusammensetzungen zur behandlung von hiv- infektionen

Country Status (11)

Country Link
EP (1) EP0607252B1 (de)
JP (1) JPH06511008A (de)
AT (1) ATE173625T1 (de)
AU (1) AU675412B2 (de)
BR (1) BR9206571A (de)
CA (1) CA2120140A1 (de)
DE (1) DE69227696T2 (de)
MX (1) MX9205549A (de)
OA (1) OA09917A (de)
PT (1) PT100914A (de)
WO (1) WO1993006832A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9303854D0 (en) * 1993-02-25 1993-04-14 Holt John A G Method for enhancing t-cell count
CA2173964A1 (en) * 1993-10-15 1995-04-20 Jess G. Thoene Prevention of hiv infection
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
CA2180732A1 (en) * 1994-01-26 1995-08-03 Shozo Shoji Anti-hiv drugs
US5734081A (en) * 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) * 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US5846958A (en) * 1995-02-17 1998-12-08 U.S. Bioscience, Inc. Methods of using aminothiols to promote hematopoietic progenitor cell growth
EP0868900A1 (de) * 1997-03-14 1998-10-07 Wella Aktiengesellschaft Mittel und Verfahren zur daurerhaften Haarverformung
JP3012923B2 (ja) * 1998-01-26 2000-02-28 新潟大学長 Ｃａｇリピート病の治療薬
US6600076B1 (en) 1999-04-05 2003-07-29 The Regents Of The University Of California Cleavable, water-soluble surfactants
AU2002353346A1 (en) * 2002-09-10 2004-04-30 Samir Chachoua Induced remission therapy
AR057623A1 (es) * 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
WO2010138419A2 (en) * 2009-05-23 2010-12-02 Obio Pharmaceutical (H.K.) Ltd. Materials and methods for treating viral infections
WO2011046901A2 (en) * 2009-10-12 2011-04-21 Walker Dale M Broad spectrum antiviral and methods of use
CN108289867A (zh) * 2015-07-02 2018-07-17 地平线孤儿病有限责任公司 Ado-抗性的半胱胺类似物和其用途
EP3429573A4 (de) 2016-03-17 2019-10-30 Thiogenesis Therapeutics, Inc. Zusammensetzungen zur kontrollierten freisetzung von cysteamin und zur systemischen behandlung von cysteaminempfindlichen erkrankungen
JP7208982B2 (ja) 2017-09-20 2023-01-19 チオジェネシス セラピューティクス， インコーポレイテッド システアミン感受性障害の治療方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055560B (it) * 1974-05-02 1982-01-11 Istituto Chemioterapico Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
EP0204989B1 (de) * 1985-06-08 1992-03-25 ASTA Medica Aktiengesellschaft Verwendung von Penicillamin zur Behandlung von Immunmangelkrankheiten
CA1339256C (en) * 1989-01-26 1997-08-12 Wulf Droge Treatment of diseases associated with hiv-infections
EP0473673A4 (en) * 1989-05-24 1995-05-17 Us Bioscience Method for protection from azt side effects and toxicity
WO1994004185A2 (en) * 1992-08-19 1994-03-03 Trustees Of Boston University Method of inhibiting reduction of disulfide bonds

Also Published As

Publication number Publication date
EP0607252A4 (en) 1996-03-13
BR9206571A (pt) 1995-10-17
JPH06511008A (ja) 1994-12-08
EP0607252B1 (de) 1998-11-25
AU2755792A (en) 1993-05-03
EP0607252A1 (de) 1994-07-27
CA2120140A1 (en) 1993-04-15
MX9205549A (es) 1993-05-01
OA09917A (en) 1994-09-15
DE69227696D1 (de) 1999-01-07
DE69227696T2 (de) 1999-05-20
PT100914A (pt) 1993-10-29
WO1993006832A1 (en) 1993-04-15
AU675412B2 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
DE69227696D1 (de) Zusammensetzungen zur behandlung von hiv-infektionen
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ES2059296T3 (es) Inhibidores de proteasas retrovirales.
DE69200685D1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE3381624D1 (de) Mittel zur behandlung von wunden.
DE69305886D1 (de) Verfahren zur bakteriellen Behandlung von mit Flora verschmutzten Kreisläufen der Papierindustrie
ATE96317T1 (de) Verwendung von 5-(subst. phenyl)oxazolidinonderivaten zur behandlung von depressionen.
DE59305800D1 (de) Werkzeug zur behandlung von oberflächen von bauteilen
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
ZA871140B (en) Synergistic chemical compositions for treating salmonellosis
RU94020393A (ru) Способ лечения вич-инфекций
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose
ATE102036T1 (de) Behandlung von hyperlipidemia mit 15-ketoprostaglandin-verbindungen.
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties